The Target

Egypt's dietary supplement industry aims to lift exports to $625 million in 2027, according to Dr. Adel Ismail, head of the Special Foods and Additives Division at the Chamber of Food Industries, speaking to Al Borsa on October 22. The goal follows a $500 million target for end-2026 and the $400 million the division says the sector exported in 2025, implying planned growth of 25% a year.

Ismail named China, Saudi Arabia, the UAE, Turkey, Sierra Leone and Togo among the main buyers. He put the number of registered factories at about 50, expected to pass 60 by end-2026 as more than 10 new plants complete licensing, with a goal of 91 within two years. Local and international companies are studying EGP 40 billion in new investment over the same period, with domestic firms expected to account for 50–60%.

Key Takeaways

  • Egypt's supplement industry targets $625M in exports in 2027, up from $400M in 2025 and a $500M goal for 2026, by the division's own figures.
  • Saudi Arabia is named among the leading export markets alongside China, the UAE and Turkey; its share was not disclosed.
  • The factory base is set to grow from about 50 to 91 within two years, backed by EGP 40B of investment under study.
  • The main exposure is upstream: raw materials and additives sourced largely from China and East Asia.

A Home Market Built to Export

The export push rests on a domestic market that has scaled quickly. Egypt has more than 14,000 registered supplements, and local manufacturing meets over 90% of demand, Ismail said. He estimated Egyptian spending on supplements at about EGP 50 billion in 2025, more than 15% of the country's pharmaceutical market, and expects 9% annual growth through 2030.

Regulation helped: registration moved from the Egyptian Drug Authority to the National Food Safety Authority, treating supplements as foods rather than medicines.

$400M
2025 Exports (Division Figure)
$500M
End-2026 Export Target
EGP 50B
Estimated Domestic Spend, 2025
15%+
Share of Egypt's Pharma Market

Why Saudi Arabia Is in the Frame

For Gulf buyers, Egypt offers proximity and competitive production costs. Saudi Arabia is the GCC's largest supplement market, estimated at roughly 57% of regional demand in 2025 and valued at $1.1–1.8 billion depending on the estimate, and it still imports most branded multivitamins, probiotics and botanicals.

That positions Egyptian producers as both suppliers and potential partners. Much of Egypt's capacity already runs as contract manufacturing; the producers' association said last year that local plants make products for around 4,500 brand-owning companies, and that it was in talks with Gulf investors to build factories in Egypt.

"Egypt is selling capacity, not only product. For Saudi brand owners, the real question is whether that capacity lands at a cost that beats Asian and European suppliers."

SFT Editorial Analysis

The Cost Side of the Target

The pressures under the target run through food supply chains across the region. Ismail cited reliance on imported raw materials and additives, mainly from China and East Asia, and said Red Sea disruption multiplied sea freight costs several times over in some cases while stretching lead times.

Some relief is arriving: container capacity through the Suez Canal passed half of 2023 levels in early October, according to BIMCO. Market access is the other constraint. In Mauritania, Ismail said, import charges can reach 65% of the goods' value.

Reading the Numbers

These are industry targets and estimates, not audited trade data. Earlier reports put exports lower, at $250 million and $350 million, and factory counts vary by source. The $1 billion 2030 ambition covers supplements and special foods together, so it is not directly comparable with the $625 million figure.

Editorial View

Egypt's target is less about one number than about positioning. An industry that grew on domestic demand now wants to be a regional manufacturing base, and Saudi Arabia is one of the markets it is counting on. For Saudi distributors, private-label owners and nutrition brands, that widens the sourcing map beyond Europe and Asia, with shorter transit times and a manufacturing base already set up for contract work.

The test is 2026. If exports reach $500 million despite imported inputs and elevated freight, the 2027 goal becomes credible and Egyptian supply becomes a real variable in Gulf procurement. If they fall short, the gap will show how much of the region's supplement trade still depends on Asian raw materials and on shipping lanes outside its control.